戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 llitus, Hashimoto's thyroiditis, and primary ovarian failure).
2 fects, including kyphoscoliosis, and primary ovarian failure.
3  other metabolic diseases, and for causes of ovarian failure.
4 vous system white matter disease and primary ovarian failure.
5 f the ovarian reserve and leads to premature ovarian failure.
6 and more common conditions such as premature ovarian failure.
7 %) of analysed SJLIFE participants had acute ovarian failure.
8 ) but could also without (type II) premature ovarian failure.
9 racterized by sensorineural hearing loss and ovarian failure.
10 bnormal follicular development and premature ovarian failure.
11 to recover and are sterile, due to premature ovarian failure.
12 ion of its function in ovaries specially for ovarian failure.
13  subfertile and exhibited signs of premature ovarian failure.
14 ized with craniofacial defects and premature ovarian failure.
15 ivors of childhood cancer develop persistent ovarian failure.
16 an further develop parkinsonism or premature ovarian failure.
17 AS in older males and females, and premature ovarian failure.
18 eterioration often associated with premature ovarian failure.
19 elopment of specialized therapies to prevent ovarian failure.
20 ncentrations had returned to those seen with ovarian failure.
21 f chemotherapy and radiotherapy is premature ovarian failure.
22 sed significantly in the women who developed ovarian failure.
23 sponsible for environmental toxicant-induced ovarian failure.
24 oss, 31.9% (95% CI, 28.0%-35.8%) for primary ovarian failure, 31.1% (95% CI, 27.3%-34.9%) for Leydig
25 licular initiation plays a role in premature ovarian failure, a common cause of infertility and prema
26 ight into the causes of idiopathic premature ovarian failure, a disease that burdens many infertile c
27 Our results indicate that the combination of ovarian failure and APOE4 leads to an exacerbation of co
28 s well as long-term complications of primary ovarian failure and cognitive dysfunction, which are die
29 g axis that activates macrophages and drives ovarian failure and female-to-male sex reversal.
30  in young women facing the risk of premature ovarian failure and infertility as a sequel to the treat
31 female mice, the event that drives premature ovarian failure and infertility in female cancer patient
32 ous disorder that leads to hypergonadotropic ovarian failure and infertility.
33  menopause is thought to be caused solely by ovarian failure and oocyte depletion.
34  exposure of females to BaP causes premature ovarian failure and ovarian tumorigenesis and that embry
35                    However, both VCD-induced ovarian failure and OVX led to a dramatic reduction in t
36 acrophage-activating ligands as mediators of ovarian failure and sex reversal.
37 omatic component most likely account for the ovarian failure and short stature.
38 (AOD) is a probable cause of human premature ovarian failure, and a potential complication of contrac
39 es of Turner syndrome include short stature, ovarian failure, and a variety of other anatomic and phy
40 sed ovulation of immature oocytes, premature ovarian failure, and compromised female fecundity.
41 be at risk of uterine artery embolization or ovarian failure, and in those in whom the ovarian artery
42  increased destruction of oogonia, premature ovarian failure, and ovarian tumorigenesis after transpl
43 gressive external ophthalmoplegia, premature ovarian failure, and Parkinson's disease.
44 sm spectrum disorder in childhood, premature ovarian failure, and the neurodegenerative disorder, fra
45 eficits on the fragile-X spectrum; premature ovarian failure; and a newly described, neurodegenerativ
46 asing hormone agonists, chemotherapy-induced ovarian failure, androgen deprivation therapy, and aroma
47            In the present study, accelerated ovarian failure (AOF) in estrogen receptor B (ERB) repor
48 ng the "postmenopausal" stage of accelerated ovarian failure (AOF) in young female mice treated with
49                                        Acute ovarian failure (AOF) occurred in 6.3% of eligible survi
50            A new rodent model of accelerated ovarian failure (AOF) successfully replicates human peri
51                            Short stature and ovarian failure are characteristic features of Turner's
52  The primary study end point was the rate of ovarian failure at 2 years, with ovarian failure defined
53 and survivors are at high risk for permanent ovarian failure at a young age.
54  survivors included older age at assessment, ovarian failure at a younger age, treatment with cranial
55 s, the development of methods for postponing ovarian failure at menopause may represent an attractive
56             The fourth patient had premature ovarian failure at the age of 13 years.
57                        One had had premature ovarian failure at the age of 14 years, whereas her sist
58           The cellular mechanisms underlying ovarian failure caused by BMP15 mutation and immune cont
59                         Chemotherapy-induced ovarian failure causes rapid and highly significant bone
60 d risk for cardiomyopathy, stroke, premature ovarian failure, chronic liver disease, and renal failur
61 l ovotoxicants plays a role in the premature ovarian failure commonly associated with infertility and
62 sceptibility in females at an early stage of ovarian failure comparable to human perimenopause.
63                                    Premature ovarian failure curtails female reproductive life and is
64 the rate of ovarian failure at 2 years, with ovarian failure defined as the absence of menses in the
65               The oldest sibling had primary ovarian failure diagnosed at age 14.5 years.
66 ozygous mutant females displayed a premature ovarian failure due to a depletion of the germ cell pool
67 linical end points: development of premature ovarian failure, end-stage renal disease (ESRD), doublin
68 ulation is depleted through natural cycling, ovarian failure follows increasing periods of acyclity.
69 et of Chinese women with sporadic, premature ovarian failure harbor mutations in FIGLA.
70 iable spectrum of somatic features including ovarian failure, heart and renal abnormalities, microgna
71         These traits included short stature, ovarian failure, high-arched palate, and autoimmune thyr
72 mong the 35 women who were defined as having ovarian failure, highly significant bone loss was observ
73 ally occurring BMP15 mutation leads to early ovarian failure in humans, and BMP15 has been shown to a
74 tened reproductive lifespan, as in premature ovarian failure in humans.
75 aluable for predicting the risk of premature ovarian failure in lupus nephritis patients treated with
76 toimmune ovarian disease (AOD) and premature ovarian failure in neonatal, but not adult, mice.
77 herapy and radiation may result in premature ovarian failure in premenopausal oncology patients.
78 ng Nobox in a manner similar to nonsyndromic ovarian failure in women.
79                                    Premature ovarian failure is a common consequence of systemic trea
80                                              Ovarian failure is a common toxic effect of chemotherapy
81                                    Premature ovarian failure is a major cause of female infertility.
82                                        Acute ovarian failure is defined as the permanent loss of ovar
83                                    Premature ovarian failure is overrepresented among females with XP
84 ndergo a true menopause, female mice exhibit ovarian failure long before death because of chronologic
85                            The time at which ovarian failure (menopause) occurs in females is determi
86              Using a VCD-induced accelerated ovarian failure model in young female C57BL/6 J and 3xTg
87                       Oocyte destruction and ovarian failure occur in PAH-treated mice, and cigarette
88 evaluate the effects of chemotherapy-induced ovarian failure on bone loss and markers of skeletal tur
89 alkylators can place women at risk for acute ovarian failure or premature menopause and men at risk f
90 diepoxide in young mice to model early-stage ovarian failure (peri-AOF) characteristic of peri-menopa
91              The genetic causes of premature ovarian failure (POF) are highly heterogeneous, and caus
92 ung women who are facing a risk of premature ovarian failure (POF) caused by radiation or chemotherap
93  or an SNP on MCM8 associated with premature ovarian failure (POF) diminishes the functional activity
94 nsanguineous family with inherited premature ovarian failure (POF) identified a homozygous frameshift
95 d not prevent chemotherapy-induced premature ovarian failure (POF) in patients with lymphoma, but may
96 ations cause gonadal dysgenesis or premature ovarian failure (POF) in women, as well as eyelid/forehe
97                                    Premature ovarian failure (POF) is a genetically and phenotypicall
98                                    Premature Ovarian Failure (POF) is a genetically heterogenous diso
99                                    Premature ovarian failure (POF) is characterized by amenorrhea and
100                                    Premature ovarian failure (POF) is characterized by elevated gonad
101                                    Premature ovarian failure (POF) is genetically heterogeneous and m
102 he impact of treatment regimens on premature ovarian failure (POF) occurrence and motherhood, includi
103      The primary end point was the premature ovarian failure (POF) rate (follicle-stimulating hormone
104 bly high incidence of irreversible premature ovarian failure (POF).
105 lkylating agent doses were at risk for acute ovarian failure, premature menopause, and small-for-gest
106           We reviewed the frequency of acute ovarian failure, premature menopause, live birth, stillb
107 35 with complete primary end-point data, the ovarian failure rate was 8% in the goserelin group and 2
108 ith chemotherapy appeared to protect against ovarian failure, reducing the risk of early menopause an
109 ificantly lower risk of developing premature ovarian failure (relative risk 0.10; 95% confidence inte
110                                   Both acute ovarian failure risk prediction models performed well.
111 his cohort study, prediction models of acute ovarian failure risk were developed using eligible femal
112 yopathy; demyelinating neuropathy; premature ovarian failure; short stature; hearing loss; pigmentary
113 east cancer who develop chemotherapy-induced ovarian failure should have their bone density monitored
114 ocytes resemble those of the human premature ovarian failure syndrome.
115 ned on a high-fat diet background we induced ovarian failure through repeated VCD injections, to mimi
116 in relation to models that ascribe premature ovarian failure to interruption of ovarian genes or to a
117 oid loss, ovariectomy and chemically-induced ovarian failure, to evaluate kainate-induced seizure act
118                         Chemotherapy-induced ovarian failure was defined as a negative pregnancy test
119                         The outcome of acute ovarian failure was defined as permanent loss of ovarian
120 nsanguineous family with inherited premature ovarian failure, we identified a homozygous 1-bp deletio
121 ausal link between macrophage activation and ovarian failure, which, in zebrafish, causes sex reversa

 
Page Top